HLB Therapeutics Co.,Ltd. (115450.KQ)

KRW 10680.0

(-2.11%)

Total Assets Summary of HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.'s latest annual total assets in 2023 was 200.79 Billion KRW , up 7.01% from previous year.
HLB Therapeutics Co.,Ltd.'s latest quarterly total assets in 2024 Q2 was 209.76 Billion KRW , down -1.03% from previous quarter.
HLB Therapeutics Co.,Ltd. reported annual total assets of 187.64 Billion KRW in 2022, down -1.09% from previous year.
HLB Therapeutics Co.,Ltd. reported annual total assets of 189.71 Billion KRW in 2021, up 55.58% from previous year.
HLB Therapeutics Co.,Ltd. reported quarterly total assets of 211.95 Billion KRW for 2024 Q1, up 5.56% from previous quarter.
HLB Therapeutics Co.,Ltd. reported quarterly total assets of 206.53 Billion KRW for 2023 Q1, up 10.07% from previous quarter.

Annual Total Assets Chart of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Historical Annual Total Assets of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	200.79 Billion KRW	7.01%
2022	187.64 Billion KRW	-1.09%
2021	189.71 Billion KRW	55.58%
2020	121.93 Billion KRW	-12.6%
2019	139.51 Billion KRW	29.6%
2018	107.65 Billion KRW	71.67%
2017	62.71 Billion KRW	21.42%
2016	51.64 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	209.76 Billion KRW	-1.03%
2024 Q1	211.95 Billion KRW	5.56%
2023 Q1	206.53 Billion KRW	10.07%
2023 Q4	200.79 Billion KRW	-5.33%
2023 Q3	212.1 Billion KRW	-0.22%
2023 Q2	212.57 Billion KRW	2.93%
2023 FY	200.79 Billion KRW	7.01%
2022 Q3	210.78 Billion KRW	2.42%
2022 Q4	187.64 Billion KRW	-10.98%
2022 Q1	192.59 Billion KRW	1.52%
2022 Q2	205.8 Billion KRW	6.86%
2021 Q3	115.95 Billion KRW	0.0%
2021 Q4	189.71 Billion KRW	63.61%

Peer Total Assets Comparison of HLB Therapeutics Co.,Ltd.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	73.289%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-103.616%
BINEX Co., Ltd.	257.01 Billion KRW	21.873%
Bioneer Corporation	315.48 Billion KRW	36.354%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-34.372%
MEDIPOST Co., Ltd.	449.39 Billion KRW	55.319%
CrystalGenomics, Inc.	243.11 Billion USD	17.408%
Helixmith Co., Ltd	227.27 Billion KRW	11.653%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	88.364%
Medy-Tox Inc.	611.62 Billion KRW	67.17%
Peptron, Inc.	52.49 Billion KRW	-282.496%
Amicogen, Inc.	467.09 Billion KRW	57.012%
Genexine, Inc.	376.58 Billion KRW	46.68%
LegoChem Biosciences, Inc.	189.5 Billion KRW	-5.959%
ALTEOGEN Inc.	256.09 Billion KRW	21.595%
PharmaResearch Co., Ltd.	535.28 Billion KRW	62.488%
SillaJen, Inc.	76.71 Billion KRW	-161.742%
JETEMA, Co., Ltd.	252.14 Billion KRW	20.366%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-95.278%
Genomictree Inc.	132.84 Billion KRW	-51.151%
MedPacto, Inc.	80.47 Billion KRW	-149.514%
D&D Pharmatech	79.2 Billion KRW	-153.517%
EASY BIO,Inc.	172.04 Billion KRW	-16.713%
GI Innovation, Inc.	81.34 Billion KRW	-146.858%